IFNG and neoplasm: We have also reported a disparity in the IFN-γ-producing capability of lipopolysaccharide (LPS)-stimulated peripheral blood cells from OSCC patients, in which the IFN-γ-producing capability was high among patients at stage I but was decreased among patients whose tumor progressions were at stages II and III.